A novel receptor - ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu.
BACKGROUND
Francisella tularensis, the causative agent of tularemia, is one of the most infectious human bacterial pathogens. It is phagocytosed by immune cells, such as monocytes and macrophages. The precise mechanisms that initiate bacterial uptake have not yet been elucidated. Participation of C3, CR3, class A scavenger receptors and mannose receptor in bacterial uptake have been already reported. However, contribution of an additional, as-yet-unidentified receptor for F. tularensis internalization has been suggested.


RESULTS
We show here that cell-surface expressed nucleolin is a receptor for Francisella tularensis Live Vaccine Strain (LVS) and promotes LVS binding and infection of human monocyte-like THP-1 cells. The HB-19 pseudopeptide that binds specifically carboxy-terminal RGG domain of nucleolin inhibits LVS binding and infection of monocyte-like THP-1 cells. In a pull-down assay, elongation factor Tu (EF-Tu), a GTP-binding protein involved in protein translation, usually found in cytoplasm, was recovered among LVS bacterial membrane proteins bound on RGG domain of nucleolin. A specific polyclonal murine antibody was raised against recombinant LVS EF-Tu. By fluorescence and electron microscopy experiments, we found that a fraction of EF-Tu could be detected at the bacterial surface. Anti-EF-Tu antibodies reduced LVS binding to monocyte-like THP-1 cells and impaired infection, even in absence of complement and complement receptors. Interaction between EF-Tu and nucleolin was illustrated by two different pull-down assays using recombinant EF-Tu proteins and either RGG domain of nucleolin or cell solubilized nucleolin.


CONCLUSIONS
Altogether, our results demonstrate that the interaction between surface nucleolin and its bacterial ligand EF-Tu plays an important role in Francisella tularensis adhesion and entry process and may therefore facilitate invasion of host tissues. Since phagosomal escape and intra-cytosolic multiplication of LVS in infected monocytes are very similar to those of human pathogenic F. tularensis ssp tularensis, the mechanism of entry into monocyte-like THP-1 cells, involving interaction between EF-Tu and nucleolin, might be similar in the two subspecies. Thus, the use of either nucleolin-specific pseudopeptide HB-19 or recombinant EF-Tu could provide attractive therapeutic approaches for modulating F. tularensis infection.
Barel
Monique
M
INSERM U570, Unité de Pathogénie des Infections Systémiques, Université Paris Descartes, Faculté de Médecine Necker Enfants-Malades, 156 rue de Vaugirard, 75730, Paris Cedex 15, France. monique.barel@inserm.fr
Hovanessian
Ara G
AG
Meibom
Karin
K
Briand
Jean-Paul
JP
Dupuis
Marion
M
Charbit
Alain
A
D000818:Animals; D000907:Antibodies, Bacterial / Q000378:metabolism; D001665:Binding Sites; D002460:Cell Line; D015536:Down-Regulation; D005604:Francisella tularensis / Q000378:metabolism / Q000502:physiology*; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D008024:Ligands; D016177:Macrophage-1 Antigen / Q000235:genetics; D008565:Membrane Proteins / Q000378:metabolism*; D051379:Mice; D009000:Monocytes / Q000378:metabolism* / Q000382:microbiology*; D010444:Peptide Elongation Factor Tu / Q000378:metabolism*; D010455:Peptides / Q000494:pharmacology; D010750:Phosphoproteins / Q000378:metabolism*; D016601:RNA-Binding Proteins / Q000378:metabolism*; D011994:Recombinant Proteins / Q000378:metabolism; D014406:Tularemia / Q000382:microbiology; D000097796:Nucleolin
D000907:Antibodies, Bacterial; D008024:Ligands; D016177:Macrophage-1 Antigen; D008565:Membrane Proteins; D010444:Peptide Elongation Factor Tu; D010455:Peptides; D010750:Phosphoproteins; D016601:RNA-Binding Proteins; D011994:Recombinant Proteins; D000097796:Nucleolin; C121944:HB-19 peptide
J Biol Chem. 1998 Aug 21;273(34):21988-97
9705340
Curr Opin Microbiol. 2003 Feb;6(1):66-71
12615222
J Immunol. 2006 Nov 1;177(9):6317-24
17056562
Cell Res. 2006 Feb;16(2):174-81
16474431
J Leukoc Biol. 2006 Sep;80(3):563-71
16816147
Ann N Y Acad Sci. 2007 Jun;1105:160-86
17435118
J Leukoc Biol. 2005 Jun;77(6):893-7
15758077
Infect Immun. 2006 Sep;74(9):5114-25
16926403
Plant Cell. 2004 Dec;16(12):3496-507
15548740
FEMS Microbiol Lett. 2005 Aug 15;249(2):359-66
16054780
Cell Microbiol. 2006 Aug;8(8):1361-70
16882038
Exp Cell Res. 2002 Jun 10;276(2):155-73
12027446
Immunol Rev. 2001 Apr;180:5-15
11414363
Eur J Biochem. 2004 Jan;271(2):303-17
14717698
Appl Environ Microbiol. 2004 Dec;70(12):7511-9
15574954
PLoS Pathog. 2006 Jul;2(7):e71
16848641
J Clin Microbiol. 1993 Jul;31(7):1936-9
8349780
J Biol Chem. 1999 Sep 24;274(39):27875-84
10488134
Mol Microbiol. 2005 Apr;56(2):383-96
15813732
Infect Immun. 2004 Jun;72(6):3204-17
15155622
Infect Immun. 2004 Apr;72(4):2160-9
15039339
J Biol Chem. 2002 Oct 4;277(40):37492-502
12147681
Microbiol Mol Biol Rev. 2007 Dec;71(4):600-19
18063719
BMC Microbiol. 2007 Jan 17;7:1
17233889
Infect Immun. 2005 Sep;73(9):5892-902
16113308
J Bacteriol. 2006 Oct;188(19):6977-85
16980500
Microbiology (Reading). 2002 Oct;148(Pt 10):3161-3171
12368450
Infect Immun. 2005 Dec;73(12):8109-18
16299305
J Biol Chem. 1992 Feb 15;267(5):2955-9
1737751
Microbiology (Reading). 2001 Feb;147(Pt 2):459-471
11158363
FEBS J. 2005 Sep;272(18):4646-59
16156786
Trends Genet. 2003 Aug;19(8):415-7
12902157
Biosci Biotechnol Biochem. 2002 Jan;66(1):1-21
11866090
J Immunol. 2007 Sep 1;179(5):2979-88
17709513
Infect Immun. 1994 Jul;62(7):2779-83
8005668
J Immunol. 2001 Mar 1;166(5):3167-73
11207269
J Immunol Methods. 1989 Aug 15;122(1):105-13
2760472
Infect Immun. 2003 Oct;71(10):5940-50
14500514
Cell. 2006 May 19;125(4):749-60
16713565
Immunol Lett. 2007 Feb 15;108(2):151-9
17241671
Exp Cell Res. 2000 Dec 15;261(2):312-28
11112338
FEBS Lett. 1984 Jan 9;165(2):175-9
6363121
JAMA. 2001 Jun 6;285(21):2763-73
11386933
Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):141-6
16373510
J Mol Biol. 1992 Feb 5;223(3):721-42
1542116
Proteomics. 2005 May;5(8):2090-103
15892173
J Cell Biol. 2003 Nov 24;163(4):871-8
14638862
J Biol Chem. 2002 Jun 7;277(23):20877-86
11919179
FASEB J. 1999 Nov;13(14):1911-22
10544174
J Biol Chem. 2002 Jan 25;277(4):2876-85
11704679
J Biol Chem. 2004 Aug 6;279(32):33751-8
15173179
Neuroscience. 2007 Aug 10;148(1):250-65
17614212
Mol Biol Rep. 1996;23(3-4):191-5
9112228